Deficiency of peripheral serotonin caused by Tph1 abrogation attenuates cerebral malaria severity

In cerebral malaria (CM), the most severe neurological complication caused by Plasmodium falciparum infection, accumulating evidence suggests that tryptophan metabolism mediates disease severity by modulating inflammation and, consequently, blood-brain barrier disruption. Here, we have established an experimental CM mouse model to dissect the differential role of the host tryptophan-serotonin metabolic axis in regulating disease pathogenesis. Peripheral serotonin-deficient mice ( Tph1 −/− ) displayed reduced mortality and blood-brain barrier permeability defects. In addition, we found that in the absence of serotonin synthesis via the enzyme Tph1, mice develop inflammation characterized by a mixed type 1 and type 2 cytokine signature. Pharmacological depletion of peripheral serotonin through injection of the Tph1 inhibitor telotristat in wild-type mice significantly improved resistance against CM. Thus, we propose that targeting serotonin synthesis through Tph1 antagonism could have a therapeutic role in P. falciparum infection and may act as a potential treatment strategy for CM. Video abstract

Authors

Institutions

Publication Details

Journal
iScience
Published
2026-10-29
DOI
https://doi.org/10.1016/j.isci.2026.118002
Primary Topic
Malaria Research and Control
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deficiency of peripheral serotonin caused by Tph1 abrogation attenuates cerebral malaria severity

Vasileios Oikonomou, Maria Teresa Antognoni, Giulia Bicchieraro, Antonella Turco et al.
2 links
iScience
Malaria Research and Control
article

Deficiency of peripheral serotonin caused by Tph1 abrogation attenuates cerebral malaria severity

Vasileios Oikonomou, Maria Teresa Antognoni, Giulia Bicchieraro, Antonella Turco, Roberta Spaccapelo, Giorgia Renga, Marco Gargaro, Carolina Colliva, Max H. Lombardi, Francesca Fallarino, Angelo Sidoni, Martina Mandarano, Claudia Floridi, Luigi Vaccaro, Teresa Zelante, Nicola Giacchè, Arianna Miglio, Gloria Iacomelli, Gianluca Vascelli, Alessia Sulla, Aurora Barbetta, Gabriele Rossini, Alicia Y.W. Wong
article en

Abstract

In cerebral malaria (CM), the most severe neurological complication caused by Plasmodium falciparum infection, accumulating evidence suggests that tryptophan metabolism mediates disease severity by modulating inflammation and, consequently, blood-brain barrier disruption. Here, we have established an experimental CM mouse model to dissect the differential role of the host tryptophan-serotonin metabolic axis in regulating disease pathogenesis. Peripheral serotonin-deficient mice ( Tph1 −/− ) displayed reduced mortality and blood-brain barrier permeability defects. In addition, we found that in the absence of serotonin synthesis via the enzyme Tph1, mice develop inflammation characterized by a mixed type 1 and type 2 cytokine signature. Pharmacological depletion of peripheral serotonin through injection of the Tph1 inhibitor telotristat in wild-type mice significantly improved resistance against CM. Thus, we propose that targeting serotonin synthesis through Tph1 antagonism could have a therapeutic role in P. falciparum infection and may act as a potential treatment strategy for CM. Video abstract

iScienceVol. 29(11)
University of Perugia (IT)
Ministero dell'Istruzione e del Merito
Good health and well-being
Openalex Percentile: Top 10%
Malaria Research and Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon